Literature DB >> 18808531

Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats.

John Albert Watts1, Michael Aaron Gellar, Maria Obraztsova, Jeffrey Allen Kline, John Zagorski.   

Abstract

Right ventricular (RV) dysfunction is associated with poor clinical outcome following pulmonary embolism (PE). Previous studies in our laboratory show that influx of neutrophils contributes to acute RV damage seen in an 18 h rat model of PE. The present study describes the further progression of inflammation over 6 weeks and compares the neutrophil and monocyte responses. The RV outflow tract became white in colour by day 1 with influx of neutrophils (tissue myeloperoxidase activity increased 17-fold) and mononuclear cells with characteristics of M1 phenotype (high in Ccl20, Cxcl10, CcR2, MHCII, DNA microarray analysis). Matrix metalloproteinase activities were increased and tissue was thinned to produce a translucent appearance in weeks 1 through 6 in 40% of hearts. RV contractile function was significantly reduced at 6 weeks of PE. In this later phase, there was accumulation of myofibroblasts, the presence of mononuclear cells with M2 characteristics (high in scavenger mannose receptors, macrophage galactose lectin 1, PDGFR1, PDGFRbeta), enrichment of the subendocardial region of the RV outflow tract with neovesels (alpha-smooth muscle immunohistochemistry) and deposition of collagen fibres (picrosirius red staining) beginning scar formation. Thus, while neutrophil response is associated with the early, acute inflammatory events, macrophage cells continue to be present during the proliferative phase and initial deposition of collagen in this model, changing from the M1 to the M2 phenotype. This suggests that the macrophage cell response is biphasic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18808531      PMCID: PMC2613983          DOI: 10.1111/j.1365-2613.2008.00610.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  36 in total

Review 1.  Macrophage polarization comes of age.

Authors:  Alberto Mantovani; Antonio Sica; Massimo Locati
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

Review 2.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

3.  Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism.

Authors:  E Giannitsis; M Müller-Bardorff; V Kurowski; B Weidtmann; U Wiegand; M Kampmann; H A Katus
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

4.  Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction.

Authors:  T Meyer; L Binder; N Hruska; H Luthe; A B Buchwald
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

5.  Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism.

Authors:  U Joseph Schoepf; Nils Kucher; Florian Kipfmueller; Rene Quiroz; Philip Costello; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

6.  The role of platelet-derived growth factor signaling in healing myocardial infarcts.

Authors:  Pawel Zymek; Marcin Bujak; Khaled Chatila; Anna Cieslak; Geeta Thakker; Mark L Entman; Nikolaos G Frangogiannis
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

7.  Right ventricular damage due to pulmonary embolism: examination of the number of infiltrating macrophages.

Authors:  Kimiharu Iwadate; Mikio Doi; Kozo Tanno; Seiko Katsumura; Haruo Ito; Keita Sato; Isamu Yonemura; Yohko Ito
Journal:  Forensic Sci Int       Date:  2003-07-08       Impact factor: 2.395

8.  Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions.

Authors:  Ulf Yrlid; Christopher D Jenkins; G Gordon MacPherson
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations.

Authors:  G J Vlahakes; K Turley; J I Hoffman
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

Review 10.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

View more
  21 in total

Review 1.  Transcriptome, proteome, and metabolome in dyssynchronous heart failure and CRT.

Authors:  Andreas S Barth; Khalid Chakir; David A Kass; Gordon F Tomaselli
Journal:  J Cardiovasc Transl Res       Date:  2012-02-07       Impact factor: 4.132

Review 2.  Fibroblasts and the extracellular matrix in right ventricular disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

3.  Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition.

Authors:  Evandro M Neto-Neves; Mary B Brown; Maria V Zaretskaia; Samin Rezania; Adam G Goodwill; Brian P McCarthy; Scott A Persohn; Paul R Territo; Jeffrey A Kline
Journal:  Am J Pathol       Date:  2017-02-07       Impact factor: 4.307

4.  The relation between international normalized ratio and mortality in acute pulmonary embolism: A retrospective study.

Authors:  Tuncay Kırış; Selcuk Yazıcı; Gündüz Durmuş; Yiğit Çanga; Mustafa Karaca; Cem Nazlı; Abdullah Dogan
Journal:  J Clin Lab Anal       Date:  2017-02-18       Impact factor: 2.352

5.  Rapid on-site evaluation of routine biochemical parameters to predict right ventricular dysfunction in and the prognosis of patients with acute pulmonary embolism upon admission to the emergency room.

Authors:  Dong Jia; Fan Liu; Qin Zhang; Guang-Qiao Zeng; Xue-Lian Li; Gang Hou
Journal:  J Clin Lab Anal       Date:  2017-11-21       Impact factor: 2.352

6.  Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism.

Authors:  Ozelia Sousa-Santos; Evandro M Neto-Neves; Karina C Ferraz; Carla S Ceron; Elen Rizzi; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

7.  Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial.

Authors:  Jeffrey A Kline; Cassandra L Hall; Alan E Jones; Michael A Puskarich; Ronald A Mastouri; Tim Lahm
Journal:  Am Heart J       Date:  2017-01-27       Impact factor: 4.749

8.  Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure.

Authors:  Jeffrey A Kline; Michael T Steuerwald; Michael R Marchick; Jackeline Hernandez-Nino; Geoffrey A Rose
Journal:  Chest       Date:  2009-06-19       Impact factor: 9.410

9.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

10.  Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.

Authors:  Evandro M Neto-Neves; Ozelia Sousa-Santos; Karina C Ferraz; Elen Rizzi; Carla S Ceron; Minna M D Romano; Luis G Gali; Benedito C Maciel; Richard Schulz; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  J Cell Mol Med       Date:  2013-11-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.